Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,909,762
-$4,702,419 QoQ
Shares Held
3,766
-61.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC WORLD MARKET INC. holds $46,729,574 across 25 Biotechnology names. REGN ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
488,266 | $13,100,176 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,078 | $12,537,950 | |
| 3 | MRNA |
Moderna, Inc.
|
69,817 | $3,546,703 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
3,766 | $2,909,762 | |
| 5 | RPRX |
Royalty Pharma plc
|
47,426 | $2,275,025 | |
| 6 | EXEL |
Exelixis, Inc.
|
38,204 | $1,638,569 | |
| 7 | ASND |
Ascendis Pharma A/S
|
6,381 | $1,459,526 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
69,215 | $1,254,867 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,909,762 | 3,766 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,612,181 | 9,862 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $8,846,193 | 15,733 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,485,350 | 4,734 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,629,971 | 2,570 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $805,645 | 1,131 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,391,841 | 1,324 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,437,809 | 1,368 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,113,600 | 1,157 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,023,207 | 1,165 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $942,289 | 1,145 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $692,672 | 964 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,747,692 | 2,127 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,757,549 | 2,436 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,487,270 | 2,159 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,003,531 | 5,081 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $4,481,062 | 6,416 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,997,521 | 6,330 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,861,410 | 8,033 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,496,673 | 4,470 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,602,998 | 3,388 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,849,828 | 3,829 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,748,752 | 3,124 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,829,302 | 12,554 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,450,221 | 2,970 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||